Procter & Gamble (NYSE:PG) Given New $191.00 Price Target at Morgan Stanley

Procter & Gamble (NYSE:PG) had its price target hoisted by equities researchers at Morgan Stanley from $174.00 to $191.00 in a report issued on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target points to a potential upside of 12.53% from the stock’s previous close.

PG has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. DA Davidson lifted their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a report on Monday. Stifel Nicolaus increased their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Finally, StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Price Performance

NYSE:PG opened at $169.73 on Monday. The firm’s fifty day moving average is $171.87 and its two-hundred day moving average is $167.43. The firm has a market cap of $400.59 billion, a price-to-earnings ratio of 29.26, a PEG ratio of 3.72 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble has a one year low of $142.50 and a one year high of $177.94.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.83 earnings per share. Research analysts expect that Procter & Gamble will post 6.98 EPS for the current year.

Insider Buying and Selling

In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now directly owns 21,513 shares of the company’s stock, valued at $3,657,210. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. 0.18% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Lloyd Advisory Services LLC. raised its position in Procter & Gamble by 493.1% in the first quarter. Lloyd Advisory Services LLC. now owns 10,990 shares of the company’s stock valued at $1,783,000 after purchasing an additional 9,137 shares during the period. Traynor Capital Management Inc. raised its holdings in shares of Procter & Gamble by 15.9% in the 1st quarter. Traynor Capital Management Inc. now owns 6,046 shares of the company’s stock valued at $981,000 after buying an additional 830 shares during the period. Southland Equity Partners LLC lifted its stake in Procter & Gamble by 12.5% during the 1st quarter. Southland Equity Partners LLC now owns 36,858 shares of the company’s stock worth $5,980,000 after acquiring an additional 4,087 shares in the last quarter. Global Assets Advisory LLC purchased a new position in Procter & Gamble during the 1st quarter valued at about $27,383,000. Finally, Financial Synergies Wealth Advisors Inc. grew its position in Procter & Gamble by 124.6% in the 1st quarter. Financial Synergies Wealth Advisors Inc. now owns 878 shares of the company’s stock valued at $142,000 after acquiring an additional 487 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.